← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2005Last known activity
Jul 1, 2020
Timeline
1990s
- Jan 1, 1993
Huntington Study Group— Founded
Drugs by trial phase (10 distinct, 12 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT04400331CollaboratorPhase 3Jul 1, 2020
- NCT04102579CollaboratorPhase 3Nov 30, 2019
- NCT02481674CollaboratorPhase 2Jul 1, 2015
- NCT02006472CollaboratorPhase 2Feb 1, 2014
- NCT01458470CollaboratorPhase 2Sep 1, 2011
- NCT00920699Lead sponsorPhase 2Feb 1, 2010
- NCT00514774CollaboratorPhase 1Aug 1, 2007
- NCT00497159CollaboratorPhase 2Jul 1, 2007
- NCT00387270CollaboratorPhase 1/Phase 2Oct 1, 2006
- NCT00277355Sponsor investigatorPhase 2/Phase 3Apr 1, 2006
- NCT00219804Overall official - principal investigatorPhase 3Sep 14, 2005
- NCT00146211CollaboratorPhase 3Sep 1, 2005
Details
- Founded
- Rochester, NY, US Jan 1, 1993
- Last known activity
- Jul 1, 2020